Cost-effectiveness of adding cetuximab to platinum-based chemotherapy for first-line treatment of recurrent or metastatic head and neck cancer.

Cost-effectiveness of adding cetuximab to platinum-based chemotherapy for first-line treatment of recurrent or metastatic head and neck cancer.

Item
http://www.wikidata.org/entity/Q34321100
Comparative Cost-Effectiveness of Drugs in Early versus Late Stages of Cancer; Review of the Literature and a Case Study in Breast CancerCost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell CarcinomaBalancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck.Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands.Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer.Cetuximab: its unique place in head and neck cancer treatmentEconomic evaluation of brentuximab vedotin for persistent Hodgkin lymphoma.A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.A systematic literature review of health state utility values in head and neck cancer.Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, CanadaHow to treat recurrent/metastatic head and neck cancer: the economic issue in real-world practice.Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada.Economic evaluation of arsenic trioxide compared to all-trans retinoic acid + conventional chemotherapy for treatment of relapsed acute promyelocytic leukemia in Canada.
P2860

Cost-effectiveness of adding cetuximab to platinum-based chemotherapy for first-line treatment of recurrent or metastatic head and neck cancer.

Item
http://www.wikidata.org/entity/Q34321100
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Cost-effectiveness of adding c ...... tastatic head and neck cancer.
@ast
Cost-effectiveness of adding c ...... tastatic head and neck cancer.
@en
Cost-effectiveness of adding c ...... tastatic head and neck cancer.
@nl
type
label
Cost-effectiveness of adding c ...... tastatic head and neck cancer.
@ast
Cost-effectiveness of adding c ...... tastatic head and neck cancer.
@en
Cost-effectiveness of adding c ...... tastatic head and neck cancer.
@nl
prefLabel
Cost-effectiveness of adding c ...... tastatic head and neck cancer.
@ast
Cost-effectiveness of adding c ...... tastatic head and neck cancer.
@en
Cost-effectiveness of adding c ...... tastatic head and neck cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Cost-effectiveness of adding c ...... tastatic head and neck cancer.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0038557
P407
P433
P478
P577
P5875
P698
P921
P932